|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
16,646,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$45.99 - $45.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Zoth Lota S |
Director |
|
2014-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,617 |
2,617 |
|
- |
|
Nunn Jason Raleigh |
Director |
|
2014-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,617 |
2,617 |
|
- |
|
Welch Daniel G |
Director |
|
2014-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,617 |
2,617 |
|
- |
|
Salehizadeh Bijan |
Director |
|
2014-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,617 |
2,617 |
|
- |
|
Healy James |
Director |
|
2014-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,617 |
14,472 |
|
- |
|
Scharschmidt Bruce Frederick |
SVP & Chief Medical Officer |
|
2014-04-01 |
4 |
OE |
$4.08 |
$32,949 |
D/D |
5,232 |
89,399 |
|
- |
|
Gould Ashley C. |
SVP Govt Aff & Chief Legal Ofc |
|
2014-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,700 |
5,700 |
|
- |
|
Scharschmidt Bruce Frederick |
SVP & Chief Medical Officer |
|
2014-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,400 |
84,167 |
|
- |
|
Holles Natalie C. |
SVP, Business Development |
|
2014-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
Santel Donald J |
CEO & President |
|
2014-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
18,500 |
|
- |
|
Nash Christine A |
SVP & Chief Commercial Officer |
|
2014-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
24,998 |
|
- |
|
Farrow Jeffrey S |
CFO & Secretary |
|
2014-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
6,250 |
|
- |
|
Dickinson Klara |
SVP Reg. Affairs & Compliance |
|
2014-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,283 |
|
- |
|
Nash Christine A |
SVP & Chief Commercial Officer |
|
2014-03-06 |
4 |
AS |
$29.03 |
$148,135 |
D/D |
(5,100) |
14,998 |
|
- |
|
Nash Christine A |
SVP & Chief Commercial Officer |
|
2014-03-06 |
4 |
OE |
$1.28 |
$19,200 |
D/D |
15,000 |
20,098 |
|
- |
|
Sofinnova Management Vii, L.l.c. |
10% Owner |
|
2014-03-04 |
4 |
AS |
$30.02 |
$709,223 |
I/I |
(23,625) |
0 |
|
- |
|
Sofinnova Management Vii, L.l.c. |
10% Owner |
|
2014-03-03 |
4 |
A |
$0.00 |
$0 |
I/I |
23,625 |
23,625 |
|
- |
|
Sofinnova Management Vii, L.l.c. |
10% Owner |
|
2014-03-03 |
4 |
AS |
$0.00 |
$0 |
I/I |
(590,000) |
2,357,221 |
|
- |
|
Nash Christine A |
SVP & Chief Commercial Officer |
|
2014-01-14 |
4 |
S |
$24.01 |
$26,412 |
D/D |
(1,100) |
5,098 |
|
- |
|
Nash Christine A |
SVP & Chief Commercial Officer |
|
2014-01-14 |
4 |
OE |
$1.28 |
$7,808 |
D/D |
6,100 |
6,198 |
|
- |
|
Nash Christine A |
SVP & Chief Commercial Officer |
|
2014-01-10 |
4 |
S |
$24.10 |
$214,489 |
D/D |
(8,900) |
98 |
|
- |
|
Nash Christine A |
SVP & Chief Commercial Officer |
|
2014-01-10 |
4 |
OE |
$1.28 |
$11,392 |
D/D |
8,900 |
8,998 |
|
- |
|
Scharschmidt Bruce Frederick |
SVP & Chief Medical Officer |
|
2014-01-06 |
4 |
OE |
$4.08 |
$45,087 |
D/D |
7,858 |
78,767 |
|
- |
|
Bay City Capital Fund V Co-Investment Fund Lp |
10% Owner |
|
2013-10-18 |
4 |
OE |
$26.00 |
$5,200,000 |
D/D |
200,000 |
35,820 |
|
- |
|
Highland Capital Partners Vii Lp |
10% Owner |
|
2013-09-20 |
4 |
S |
$25.81 |
$110,983 |
I/I |
(4,300) |
38,616 |
|
- |
|
241 Records found
|
|
Page 5 of 10 |
|
|